Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-Current Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Non-Current Assets for 11 consecutive years, with $24.9 million as the latest value for Q3 2025.

  • Quarterly Non-Current Assets fell 55.94% to $24.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $143.7 million through Sep 2025, down 67.92% year-over-year, with the annual reading at $52.3 million for FY2024, 66.98% down from the prior year.
  • Non-Current Assets for Q3 2025 was $24.9 million at Editas Medicine, down from $27.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $170.2 million in Q4 2021, with the low at $24.9 million in Q3 2025.
  • Average Non-Current Assets over 5 years is $110.2 million, with a median of $126.1 million recorded in 2022.
  • The sharpest move saw Non-Current Assets surged 255.45% in 2021, then crashed 71.78% in 2025.
  • Over 5 years, Non-Current Assets stood at $170.2 million in 2021, then dropped by 7.41% to $157.6 million in 2022, then grew by 0.48% to $158.3 million in 2023, then tumbled by 66.98% to $52.3 million in 2024, then crashed by 52.44% to $24.9 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $24.9 million, $27.8 million, and $38.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.